Maha A. Hilal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Maha A. Hilal has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Mosab M. Rashwan
Forensic Medicine & Clinical Toxicology Department, Faculty of Medicine, Sohag University, Sohag, Egypt
2 shared publications Walaa Allam
Forensic Medicine & Clinical Toxicology Department, Faculty of Medicine, Sohag University, Sohag, Egypt
2 shared publicationsEman A. Mohamed
1 shared publication- Hoda Mohamed El Sayed
Histology & Cell Biology, Faculty of Medicine, Sohag University, Sohag, Egypt
1 shared publication - Hoda Samir El-Sayed
Dairy Science Department, Food Industries and Nutrition Institute, National Research Centre, Dokki, Cairo 12622, Egypt
1 shared publication Khaled E. Aboul-Hagag
1 shared publication
Latest Publications
- Open Access
- 1 July 2022
- Published by Egyptian Knowledge Bank in Ain Shams Journal of Forensic Medicine and Clinical Toxicology
- Vol. 39 (2) , 72-76
Review on AMB-FUBINACA one of synthetic cannabinoids present in Egypt
Background: Synthetic cannabinoids are currently the largest group of new psychoactive substances. Those that have been subjected to legal control are replaced by newer uncontrolled substances, which cause constant and dynamic changes to the drug market. AMB-FUBINACA is one of the recent synthetic cannabinoids appeared globally. In 2018, the official spokesman for the Ministry of Health in Egypt announced that the Strox consists of five types of synthetic cannabinoids which have been added to the Egyptian list of highly addictive and dangerous narcotics. These SCs are; AB-FUBINACA, AMB-FUBINACA, 5F-ADB, AB-CHMINACA, and XLR-11. Aim of the work: To spotlight the toxic effect of AMB-FUBINACA as a new synthetic cannabinoid. Conclusion: AMB-FUBINACA has been the focus of interest by health care professionals, as their use put the health of many humans at risk especially young adults. Received in original form: 24 December 2021 Accepted in a final form: 30 June 2022
- 1 July 2022
- Published by Egyptian Knowledge Bank in Ain Shams Journal of Forensic Medicine and Clinical Toxicology
- Vol. 39 (2) , 72-76
Open AccessReview on AMB-FUBINACA one of synthetic cannabinoids present in Egypt
Background: Synthetic cannabinoids are currently the largest group of new psychoactive substances. Those that have been subjected to legal control are replaced by newer uncontrolled substances, which cause constant and dynamic changes to the drug market. AMB-FUBINACA is one of the recent synthetic cannabinoids appeared globally. In 2018, the official spokesman for the Ministry of Health in Egypt announced that the Strox consists of five types of synthetic cannabinoids which have been added to the Egyptian list of highly addictive and dangerous narcotics. These SCs are; AB-FUBINACA, AMB-FUBINACA, 5F-ADB, AB-CHMINACA, and XLR-11. Aim of the work: To spotlight the toxic effect of AMB-FUBINACA as a new synthetic cannabinoid. Conclusion: AMB-FUBINACA has been the focus of interest by health care professionals, as their use put the health of many humans at risk especially young adults. Received in original form: 24 December 2021 Accepted in a final form: 30 June 2022
- Open Access
- 1 July 2022
- Published by Egyptian Knowledge Bank in Ain Shams Journal of Forensic Medicine and Clinical Toxicology
- Vol. 39 (2) , 56-61
Experimental Study on Sub-acute Testicular Toxicity of AMB-FUBINACA in Adult Male Albino Rats
Background: AMB-FUBINACA abuse was confirmed in case reports of a mass intoxication in the United States. Also it was reported that in New Zealand, there were at least 20 deaths related to the use of MMB-FUBINACA. Aim of the Work: To detect the toxic effect of synthetic cannabinoid (AMB-FUBINACA) with different doses on the testis of adult male albino rats histopathologically and Biochemically. Methods: the present work was conducted on 40 sexually mature male albino rats. Rats were divided into 5 groups 8 rats each as follow Group I: Negative control group, Group II: Positive control group where animals received ethanol 5%, Group III: Rats treated with AMB-FUBINACA at dose of 2.5 mg/kg dissolved in ethanol 5%, Group IV: Rats treated with AMB-FUBINACA at dose of 5 mg/kg dissolved in ethanol 5% and Group V: Rats treated with AMB-FUBINACA at dose of 10 mg/kg dissolved in ethanol 5% given by intraperitoneal injection for 4 weeks. Results: a significant decrease of testosterone level in AMB-FUBINACA treated groups compared to the control groups and degenerative changes in seminiferous tubules was also observed in treated groups. Conclusion: administration of AMB-FUBINACA for 4weeks was associated with toxic effects in testis
- 1 July 2022
- Published by Egyptian Knowledge Bank in Ain Shams Journal of Forensic Medicine and Clinical Toxicology
- Vol. 39 (2) , 56-61
Open AccessExperimental Study on Sub-acute Testicular Toxicity of AMB-FUBINACA in Adult Male Albino Rats
Background: AMB-FUBINACA abuse was confirmed in case reports of a mass intoxication in the United States. Also it was reported that in New Zealand, there were at least 20 deaths related to the use of MMB-FUBINACA. Aim of the Work: To detect the toxic effect of synthetic cannabinoid (AMB-FUBINACA) with different doses on the testis of adult male albino rats histopathologically and Biochemically. Methods: the present work was conducted on 40 sexually mature male albino rats. Rats were divided into 5 groups 8 rats each as follow Group I: Negative control group, Group II: Positive control group where animals received ethanol 5%, Group III: Rats treated with AMB-FUBINACA at dose of 2.5 mg/kg dissolved in ethanol 5%, Group IV: Rats treated with AMB-FUBINACA at dose of 5 mg/kg dissolved in ethanol 5% and Group V: Rats treated with AMB-FUBINACA at dose of 10 mg/kg dissolved in ethanol 5% given by intraperitoneal injection for 4 weeks. Results: a significant decrease of testosterone level in AMB-FUBINACA treated groups compared to the control groups and degenerative changes in seminiferous tubules was also observed in treated groups. Conclusion: administration of AMB-FUBINACA for 4weeks was associated with toxic effects in testis
- Open Access
- 1 December 2013
- Published by Oxford University Press (OUP) in Journal of Chromatographic Science
- Vol. 52 (10) , 1186-1192
Simultaneous Determination of Tramadol and O-Desmethyltramadol in Human Plasma Using HPLC–DAD
A sensitive and accurate method for the extraction and quantification of tramadol (T) and its active metabolite, O-desmethyltramadol (ODT) in human plasma with high-performance liquid chromatography–diode array detection was developed and validated. The analytes were extracted from plasma samples by tert-butylmethyl ether in the presence of ammonium hydroxide as alkaline medium and back extraction with 1.0 M hydrochloric acid. Propranolol was used as internal standard. The extraction efficiencies of T and ODT were 83.51 and 78.72%, respectively. The calibration curves were linear (r2 > 0.99) in the concentration range of 250–2000 ng/mL for T and ODT. Limits of detection and quantification were 125 and 250 ng/mL for both analytes. Intra- and interassay precision for T and ODT were ranged from 1.89 to 10.91% and 2.16 to 5.85%, respectively. Intra- and interassay accuracy for T and ODT were ranged from −13.07 to 4.99% and −2.03 to −6.98%, respectively. The method was successfully applied to quantify T and ODT from authentic plasma samples received from Hospital Sohag University. The method was completely validated and can be of interest to clinical and forensic laboratories.
- 1 December 2013
- Published by Oxford University Press (OUP) in Journal of Chromatographic Science
- Vol. 52 (10) , 1186-1192
Open AccessSimultaneous Determination of Tramadol and O-Desmethyltramadol in Human Plasma Using HPLC–DAD
A sensitive and accurate method for the extraction and quantification of tramadol (T) and its active metabolite, O-desmethyltramadol (ODT) in human plasma with high-performance liquid chromatography–diode array detection was developed and validated. The analytes were extracted from plasma samples by tert-butylmethyl ether in the presence of ammonium hydroxide as alkaline medium and back extraction with 1.0 M hydrochloric acid. Propranolol was used as internal standard. The extraction efficiencies of T and ODT were 83.51 and 78.72%, respectively. The calibration curves were linear (r2 > 0.99) in the concentration range of 250–2000 ng/mL for T and ODT. Limits of detection and quantification were 125 and 250 ng/mL for both analytes. Intra- and interassay precision for T and ODT were ranged from 1.89 to 10.91% and 2.16 to 5.85%, respectively. Intra- and interassay accuracy for T and ODT were ranged from −13.07 to 4.99% and −2.03 to −6.98%, respectively. The method was successfully applied to quantify T and ODT from authentic plasma samples received from Hospital Sohag University. The method was completely validated and can be of interest to clinical and forensic laboratories.
- Open Access
- 1 June 2011
- Published by Springer Nature in Egyptian Journal of Forensic Sciences
- Vol. 1 (2) , 80-86
Determination of sex from hand dimensions and index/ring finger length ratio in Upper Egyptians
- 1 June 2011
- Published by Springer Nature in Egyptian Journal of Forensic Sciences
- Vol. 1 (2) , 80-86
Open AccessDetermination of sex from hand dimensions and index/ring finger length ratio in Upper Egyptians